Liver Tumours and Nodular Lesions

2019 ◽  
pp. 345-359
Author(s):  
Chayarani Kelgeri ◽  
Khalid Sharif ◽  
Ulrich Baumann
Keyword(s):  
Liver Tumours ◽  
Nodular Lesions

Our experience in the surgical treatment of metastatic liver tumours

2004 ◽  
Vol 42 (05) ◽  
Author(s):  
J Pósán ◽  
A Vágvölgyi ◽  
I Takács ◽  
A Furka ◽  
M Boland ◽  
...  
Keyword(s):  
Surgical Treatment ◽  
Liver Tumours ◽  
Metastatic Liver

Tight junction proteins in HCC and metastatic liver tumours

2005 ◽  
Vol 43 (05) ◽  
Author(s):  
Cs Páska ◽  
E Orbán ◽  
A Kiss ◽  
Zs Schaff ◽  
A Szijjártó ◽  
...  
Keyword(s):  
Tight Junction ◽  
Tight Junction Proteins ◽  
Liver Tumours ◽  
Metastatic Liver ◽  
Junction Proteins

Laparoscopic surgery of benign liver tumours

2015 ◽  
Vol 68 (1) ◽  
pp. 3-7 ◽  
Author(s):  
Péter Kupcsulik ◽  
Oszkár Hahn ◽  
Attila Szíjártó ◽  
Attila Zsirka ◽  
Tamás Winternitz ◽  
...  
Keyword(s):  
Laparoscopic Surgery ◽  
Liver Tumours ◽  
Benign Liver

Munkahelyünkön 2004–2014 között 273 elektív műtét történt benignus májelváltozás miatt. 83 esetben laparoszkópos (LAP) beavatkozásra került sor: cystafenestratio 52, májresectio 31 esetben történt. A LAP resectiókat hasonló demográfiai és klinikai jellemzőkkel bíró betegek nyitott műtéteivel összehasonlítva megállapítható, hogy a műtéti idő a LAP csoportban (113,7 perc) szignifikánsan hosszabb volt, mint a nyitott műtéteknél (89,5 perc), a kórházi ápolási idő viszont rövidebb (5,8 vs 9,1 nap). Posztoperatív szövődmény a LAP csoportban nem volt, nyitott műtétek után két sebgennyedés, egy UH-vezérelt drainezést igénylő epegyülem fordult elő. A nyitott csoportban 4, a LAP csoportban 3 beteg igényelt transzfúziót. Műtéti halálozás nem volt, reoperációra nem került sor. A közleményben részletezett műtéti technika biztonságos resectiót tesz lehetővé a máj nehezen hozzáférhető, 7–8. szegmentuma területén is. Az eredmények alapján a LAP májresectio megfelelő preoperatív vizsgálatok birtokában választható módszer májdaganatok sebészi kezelésére.

Application of hydro-dissection technique in percutaneous thermal ablation of neck nodular lesions

2014 ◽  
Vol 35 (10) ◽  
pp. 1045
Author(s):  
Jian-quan ZHANG ◽  
Jian-guo SHENG ◽  
Zong-ping DIAO ◽  
Lu-lu ZHAO ◽  
Hang ZHANG
Keyword(s):  
Thermal Ablation ◽  
Nodular Lesions ◽  
Percutaneous Thermal Ablation ◽  
Dissection Technique

Magnetic Resonance Imaging of Uncommon Hepatic Mesenchymal Tumours: Haemangioendothelioma and Angiosarcoma

2019 ◽  
Vol 15 (4) ◽  
pp. 362-368
Author(s):  
Andrzej Cieszanowski ◽  
Agnieszka Anysz-Grodzicka ◽  
Joanna Podgorska ◽  
Beata Jagielska ◽  
Jakub Pałucki
Keyword(s):  
Contrast Enhancement ◽  
Correct Diagnosis ◽  
Malignant Potential ◽  
Hepatobiliary Phase ◽  
Imaging Features ◽  
Liver Tumours ◽  
Aged Woman ◽  
High Apparent Diffusion Coefficient ◽  
Adc Values ◽  
Mesenchymal Tumours

<P>Background: Primary Hepatic Epithelioid Haemangioendothelioma (HEHE) and Primary Hepatic Angiosarcoma (PHA) are rare mesenchymal tumours with different malignant potential. Whereas HEHE demonstrates low to intermediate malignant potential, PHA is an aggressive malignancy with poor prognosis. The knowledge of typical imaging features of these lesions may facilitate correct diagnosis; however, the ultimate diagnosis of HEHE and PHA is based on histopathologic examination. </P><P> Discussion: The most typical findings helpful in diagnosing HEHE are: Presence of multiple, confluent nodules located at the liver periphery (in young to middle-aged woman), retraction of the liver capsule, marked hyperintensity on T2-weighted images, “target-sign” appearance, progressive centripetal contrast enhancement, and relatively high Apparent Diffusion Coefficient (ADC) values. More than &#8805;50% of nodules are hyper- or isointense on Hepatobiliary Phase (HBP) images. Conclusion: The imaging features suggestive of PHA are: Occurrence of metastases (lungs, spleen) at the time of diagnosis, presence of a large dominant mass with smaller satellites, heterogeneity and areas of haemorrhage in a dominant mass, progressive contrast enhancement, slightly elevated ADC values as compared to other malignant liver tumours.</P>

scholarly journals FRI0167 Clinicopathologic evaluation of nodular lesions of behÇet’s disease

2001 ◽  
Author(s):  
C Demirkesen ◽  
N Tüzüner ◽  
C Mat ◽  
M Senocak ◽  
N Büyükbabani ◽  
...  
Keyword(s):  
Behçet’S Disease ◽  
Behcet’S Disease ◽  
Behçet's Disease ◽  
Behcet's Disease ◽  
Nodular Lesions

scholarly journals Massive peripheral giant cell granuloma associated with pregnancy

2016 ◽  
Author(s):  
Vikas Jain
Keyword(s):  
Oral Cavity ◽  
Giant Cell ◽  
Ovarian Hormones ◽  
Contributory Factor ◽  
Hormonal Changes ◽  
Giant Cell Granuloma ◽  
Young Females ◽  
Peripheral Giant Cell Granuloma ◽  
Nodular Lesions

Peripheral giant cell granuloma (PGCG) is a relatively Common reactive exophytic lesion of the oral cavity. The influence of hormones has been suggested as contributory factor in PGCG development and predominance of these lesions in young females as well as some previously reported pregnancy related cases support this belief. It has been observed that majority of lesions present in the 4th decade of life, when hormonal changes are more pronounced. Cailluette and Mattar in their study found that peripheral giant cell granuloma are under the influence of the ovarian hormones. However Chambers and Spector suggested peripheral giant cell granuloma to be enhanced by pregnancy rather than being pregnancy dependent. The responsiveness of gingiva to these hormones along with the immunosuppressive actions of the hormones contributes to the growth of the lesion. Clinically, PGCGs may present as polypoid or nodular lesions, predominantly bluish red with a smooth shiny or mamillated surface.This poster will review the literature available on the association of Massive Peripheral Giant Cell Granuloma With Pregnancy with focus on possible causes of PGCG during pregnancy.

scholarly journals 466 Resection or Enucleation for Extremely Giant Hepatic Haemangiomata? A Case Report and Review of The Literature

2021 ◽  
Vol 108 (Supplement_2) ◽  
Author(s):  
R E Fraser ◽  
G R Layton ◽  
L L Kuan ◽  
A R Dennison
Keyword(s):  
Expectant Management ◽  
Evidence Base ◽  
Primary Treatment ◽  
Cavernous Haemangioma ◽  
Liver Tumours ◽  
Case Presentation ◽  
Best Management ◽  
Anatomical Liver Resection ◽  
Benign Liver

Abstract Background Cavernous hepatic haemangiomas are benign liver tumours and although common when small, giant haemangiomas (usually accepted as being greater than 10cm) are infrequent. Treatment is indicated in patients who are symptomatic or if diagnosis is unclear, although with giant haemangiomas, many support expectant management of asymptomatic lesions due to the risk of major complications. Traditionally hepatic resection has been the primary treatment option for these lesions, but a variety of other techniques, including enucleation, have been described as safe and effective alternatives. There remains equipoise in respect of the best management of giant haemangiomas above 10cm. Cases of such size are rare and so there is a paucity of data available. Case presentation We present a case of a 65-year-old male who underwent successful anatomical liver resection for a 5kg giant cavernous haemangioma of 26cm diameter following its incidental identification during an ultrasound scan. We also discuss and compare the role of resection and enucleation for the treatment of haemangiomata greater than 20cm in diameter. Conclusions This case demonstrates successful resection of an unusually giant haemangioma which, in contrast to the majority of literature, provides a valuable addition to the limited evidence base for management of this condition by anatomical resection.

Sign in / Sign up

Export Citation Format

Share Document